Novo Nordisk A/S will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its more efficient rival Eli Lilly & Co. in the booming obesity drug market.
Novo Nordisk A/S will slash 9,000 jobs globally and cut its profit forecast for the third time this year as it fights to recover ground lost to its more efficient rival Eli Lilly & Co. in the boo…
Artikel ini bersumber dari Bloomberg pada September 10, 2025 at 5:38 AM.
To view and participate in discussions about this article, please visit the original source.
View Original Article